Oral heparin data

EMIS and ELN announced Phase I results with oral delivery of the anti-clotting agent heparin, previously active only via injection. The double-blind, placebo-controlled study demonstrated clinically relevant levels of heparin with oral dosing, and the product was shown to be safe. ...